Consistent with the effect on the cell proliferation, atorvastatin treatment significantly down-regulated the mRNA level of PBK in the ER- breast cancer MDA-MB-231 cells, but not in MCF7 cells (Figure 2A). This evidence concerns the gene PBK and breast carcinoma.